AXA S.A. Stock
€45.38
Your prediction
AXA S.A. Stock
Discovering AXA: An Overview
Let's dive into the world of AXA (ticker symbol: AXAHF, WKN 855705), a prominent global insurance and asset management firm. Founded in 1817 and headquartered in Paris, France, AXA serves millions of customers across 62 countries with a diverse array of insurance products and services, including life, health, property, and casualty insurance. Boasting a strong and dynamic workforce of over 160,000 employees and financial advisors, the company is committed to creating tailor-made solutions for individual customers, SMEs, and large corporations alike. As a testament to its robust financial stability and market influence, AXA ranked #33 on the 2021 Global Fortune 500 list. Committed to corporate responsibility, this powerhouse also actively addresses pressing social and environmental issues through strategic investments focused on sustainability and social cohesion. In navigating the ever-evolving financial world, AXA's insurance and management expertise keeps it poised for continued success, making it a likely staple in investment portfolios around the globe.
Pros and Cons of AXA S.A. in the next few years
Pros
Cons
Performance of AXA S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AXA S.A. | 1.680% | -0.157% | 3.670% | 5.808% | 8.431% | 61.206% | 105.054% |
| Lincoln National | -0.960% | -2.763% | 12.363% | 21.079% | -7.019% | 44.641% | -25.826% |
| Metlife Inc. | 0.650% | 1.509% | 12.067% | 24.682% | 22.395% | 49.355% | 66.800% |
| Aflac Inc. | 0.630% | 1.330% | 6.301% | 25.483% | 18.131% | 68.189% | 143.768% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.AXA’s 2025 results present a picture of a large insurer generating strong headline earnings, supported by a one-time gain. Group revenue advanced modestly by around four percent to €91.1 billion, while reported net income surged nearly 24 percent to almost €10 billion. However, this profit jump needs to be viewed in the context of a significant contribution from discontinued operations, which makes the underlying operating performance a more nuanced story.
Regarding revenue and profitability, the top line has been recovering from a dip in 2022, though the five-year compound annual growth rate for revenue remains slightly negative. Net income has climbed steadily since 2020, but the latest improvement in the net margin—to nearly 11 percent from just above 9 percent—was amplified by the €2.35 billion profit from discontinued items. Excluding that, profit from continuing operations would have been substantially lower, and the operating margin from continuing activities actually edged down to 11.4 percent from 11.9 percent a year earlier. The gap between the modest revenue growth and the strong net income increase could therefore be largely attributable to that non-recurring element.
The balance sheet remains conservatively structured with a net cash position of €22.2 billion and no conventional gross debt, keeping debt ratios at zero. Total equity attributable to owners of the parent declined by roughly 5.5 percent year-on-year, partly reflecting significant returns to shareholders; per-share dividends reached €2.15 and the number of outstanding shares fell by over 124 million, suggesting active share buybacks. This reduction in the equity base mechanically lifted return on equity above 21 percent, a level that may not be fully sustainable without the discontinued gain. Goodwill and intangible assets of over €22 billion represent a notable portion of the asset side, and the huge insurance contract liabilities—making up the bulk of the balance sheet—underline the capital-intensive nature of the business.
